Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome

Abstract Background Cripto-1 (CR-1) has been reported to be involved in the development of several human cancers. The potential role of CR-1 in clear cell renal cell carcinoma (ccRCC) is still not clear. Methods CR-1 expression was evaluated in ccRCC tissues by Real-time quantitative PCR, Western bl...

Full description

Bibliographic Details
Main Authors:	Yi-Jun Xue, Song-Ning Chen, Wei-Guang Chen, Geng-Qing Wu, Yun-Feng Liao, Jian-Bin Xu, Hao Tang, Shui-Hua Yang, Shui-Yong He, Yun-Fei Luo, Zhi-Hui Wu, Hai-Wen Huang
Format:	Article
Language:	English
Published:	BMC 2019-08-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	Clear cell renal cell carcinoma Cripto-1 Prognosis
Online Access:	http://link.springer.com/article/10.1186/s13046-019-1386-6

Similar Items

Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma
by: Qiang Liu, et al.
Published: (2017-04-01)

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
by: Md Jahangir Alam, et al.
Published: (2018-10-01)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
by: David W. Freeman, et al.
Published: (2021-09-01)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
by: Hiroko Ishii, et al.
Published: (2021-05-01)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
by: Chunxiao Hu, et al.
Published: (2021-08-01)

Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration
by: Carolina ePrezioso, et al.
Published: (2015-05-01)

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth
by: Hiroko Ishii, et al.
Published: (2021-02-01)

CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress
by: Ozlen Balcioglu, et al.
Published: (2020-11-01)

Biological and Clinicopathological Significance of Cripto-1 Expression in the Progression of Human ESCC
by: Reihaneh Alsadat Mahmoudian, et al.
Published: (2017-05-01)

Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells
by: Hilal Arnouk, et al.
Published: (2021-08-01)

CRIPTO1: expressão e possíveis ações sobre as células citotrofoblásticas extravilosas humanas.
by: Bandeira, Carla Letícia dos Santos
Published: (2015)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma
by: Qing Ye, et al.
Published: (2020-09-01)

New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
by: Paola Arboretto, et al.
Published: (2021-07-01)

Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
by: Yicong Yao, et al.
Published: (2021-05-01)

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
by: Yicong Yao, et al.
Published: (2021-07-01)

CRIPTO and miR-371a-3p Are Serum Biomarkers of Testicular Germ Cell Tumors and Are Detected in Seminal Plasma from Azoospermic Males
by: Cassy M. Spiller, et al.
Published: (2020-03-01)

Low level of Cyclin‐D1 correlates with worse prognosis of clear cell renal cell carcinoma patients
by: Qing‐shui Wang, et al.
Published: (2019-08-01)

Increased expression of RUNX1 in clear cell renal cell carcinoma predicts poor prognosis
by: Yang Fu, et al.
Published: (2019-10-01)

Commentary: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma
by: Mustafa Zafer Temiz
Published: (2021-10-01)

Overexpression of IRF3 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma
by: Wu J, et al.
Published: (2021-09-01)

Overexpression of HHLA2 in human clear cell renal cell carcinoma is significantly associated with poor survival of the patients
by: Lujun Chen, et al.
Published: (2019-04-01)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
by: Wenbiao Zhu, et al.
Published: (2021-09-01)

Dysregulation of Ketone Body Metabolism Is Associated With Poor Prognosis for Clear Cell Renal Cell Carcinoma Patients
by: Wanmeng Cui, et al.
Published: (2019-12-01)

High expression of CDCA7 predicts poor prognosis for clear cell renal cell carcinoma and explores its associations with immunity
by: Shouyong Liu, et al.
Published: (2021-03-01)

A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
by: Elisa Rodrigues Sousa, et al.
Published: (2020-06-01)

Regulation of fetal male germ cell development by members of the TGFβ superfamily
by: Cassy Spiller, et al.
Published: (2017-10-01)

CARS as a Prognosis Factor in Clear Cell Renal Cell Carcinoma and Its Association with Tumor Immunity
by: Meng Q, et al.
Published: (2021-07-01)

Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data
by: Jiang-hui Zeng, et al.
Published: (2019-08-01)

Expressão do fator cripto-1 na interface materno-placentária em camundongos
by: Carla Letícia dos Santos Bandeira
Published: (2009)

Expressão do fator cripto-1 na interface materno-placentária em camundongos
by: Bandeira, Carla Letícia dos Santos
Published: (2009)

Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma
by: Wen-Hao Xu, et al.
Published: (2019-11-01)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
by: Meng Q, et al.
Published: (2021-07-01)

Prognostic role of PHYH for overall survival (OS) in clear cell renal cell carcinoma (ccRCC)
by: Qiu Zhengqi, et al.
Published: (2021-01-01)

Angiogenesis-Related Molecular Subtypes and a Novel Prognostic Signature in Clear Cell Renal Cell Carcinoma Patients
by: Li H, et al.
Published: (2021-10-01)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
by: Mingzhe Jiang, et al.
Published: (2020-06-01)

Development of an Individualized Ubiquitin Prognostic Signature for Clear Cell Renal Cell Carcinoma
by: Yue Wu, et al.
Published: (2021-06-01)

Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma
by: Feng G, et al.
Published: (2019-02-01)

Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma
by: Zhang GH, et al.
Published: (2018-09-01)

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
by: Emma Andersson Evelönn, et al.
Published: (2019-01-01)

STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion
by: Tuo Deng, et al.
Published: (2021-04-01)